Altamirano-Bustamante, Nelly F; Garrido-Magana, Eulalia; Moran, Eugenia; Calderon, Aurora; Pasten-Hidalgo, Karina; Angelica Castillo-Rodriguez, Rosa; Rojas, Gerardo; Lara-Martinez, Reyna; Leyva-Garcia, Edgar; Larralde-Laborde, Mateo; Domiguez, Guadalupe; Murata, Chiharu; Margarita-Vazquez, Yolanda; Payro, Rafael; Barbosa, Manuel; Valderrama, Alejandro; Montesinos, Hortencia; Dominguez-Camacho, Alejandra; Garcia-Olmos, Victor H; Ferrer, Regina; Medina-Bravo, Patricia G; Santoscoy, Fernanda; Revilla-Monsalve, Cristina; Felipe Jimenez-Garcia, Luis; Moran, Julio; Villalobos-Alva, Jalil; Javier Villalobos, Mario; Calzada-Leon, Raul; Altamirano, Perla; Altamirano-Bustamante, Myriam M (2020)
PROTEIN-CONFORMATIONAL DISEASES IN CHILDHOOD: NATURALLY-OCCURRING HIAPP AMYLOID-OLIGOMERS AND EARLY BETA-CELL DAMAGE IN OBESITY AND DIABETES
PLoS ONE 15(8):
This is the first time that obesity and diabetes mellitus (DM) as protein conformational diseases (PCD) are reported in children and they are typically diagnosed too late, when β-cell damage is evident. Here we wanted to investigate the level of naturally-ocurring or real (not synthetic) oligomeric aggregates of the human islet amyloid polypeptide (hIAPP) that we called RIAO in sera of pediatric patients with obesity and diabetes. We aimed to reduce the gap between basic biomedical research, clinical practice-health decision making and to explore whether RIAO work as a potential biomarker of early β-cell damage.